VAPO (Vapotherm) Common Stock : $0.01 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Vapotherm Common Stock?

Vapotherm's quarterly common stock stayed the same from Dec. 2023 ($0.01 Mil) to Mar. 2024 ($0.01 Mil) and stayed the same from Mar. 2024 ($0.01 Mil) to Jun. 2024 ($0.01 Mil).

Vapotherm's annual common stock declined from Dec. 2021 ($0.03 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.01 Mil).

Vapotherm Common Stock Historical Data

The historical data trend for Vapotherm's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vapotherm Common Stock Chart

Vapotherm Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.02

0.03

0.01

Vapotherm Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Common Stock	Get a 7-Day Free Trial															0.05	0.01	0.01	0.01	0.01

Vapotherm Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Vapotherm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vapotherm Inc (OTCPK:VAPO) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Domain Drive, Exeter, NH, USA, 03833

Website

https://www.vapotherm.com

Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Precision Flow Heliox and others. It generates revenue from sales of products to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.

Executives

James W Liken	director	5 DEER SPRING LANE, PITTSBURGH PA 15211
Joseph Army	director, officer: President and CEO	ONE WASHINGTON CENTER, SUITE 400, DOVER NH 03820
Anthony L. Arnerich	director	100 DOMAIN DRIVE, EXETER NH 03833
Dorota Mckay	officer: Chief Accounting Officer	100 DOMAIN DRIVE, EXETER NH 03833
John Landry	officer: See Remarks	100 DOMAIN DRIVE, EXETER NH 03833
Lance A Berry	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Elizabeth H Weatherman	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Richard R Barrera	10 percent owner	767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Holdings Llc	10 percent owner	767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Management Lp	10 percent owner	780 THIRD AVENUE, 41ST FLOOR, NEW YORK NY 10017
Brian Lawrence	officer: SVP & Chief Technology Officer	100 DOMAIN DRIVE, EXETER NH 03833
Prescott General Partners Llc	10 percent owner, other: Member of Section 13(d) Group	2200 BUTTS ROAD, SUITE 320, BOCA RATON FL 33431
Gregoire Ramade	officer: Vice President, International	100 DOMAIN DRIVE, EXETER NH 03833
Joel F. Dube	officer: Chief Accounting Officer	100 DOMAIN DRIVE, EXETER NH 03833
Donald J Spence	director	C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304